New trial aims to shield blood cancer patients from deadly infections

NCT ID NCT07202065

Recruiting now Disease control Sponsor: Monash University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at different ways to prevent serious infections in people with blood cancers like myeloma, lymphoma, and leukemia. About 900 participants will receive either antibiotics or immunoglobulin therapy to see which approach works best. The goal is to find safer and more effective infection control methods for these vulnerable patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Infections leukemia lymphoma neoplasm non-Hodgkin lymphoma plasma cell myeloma plasma cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LEUKEMIA MYELOMA NON-HODGKIN'S LYMPHOMA

Contacts and locations

Locations

Austin Hospital
RECRUITING

Melbourne, Victoria, 3004, Australia
Northern Health
RECRUITING

Melbourne, Victoria, 3004, Australia
Royal Adelaide Hospital
RECRUITING

Adelaide, South Australia, 5000, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.